Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (4331)	7/18/2001 11:15:41 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 52153

>> "The FDA continues to uphold its traditional high standards... The rate of drug withdrawals for safety in the U.S. has remained steady...2.7 percent...for the past 30 years. All drugs have risks, and to imply otherwise is to mislead patients." << I've been ass'd with the pharma and biotech industries for twenty years. I've been to Bethesda, worked "with" FDA, etc. Take home lesson......... CBS is full of it. Most small molecules are poisons. Some of those poisons are valuable medicines. This "do no harm" crap and its proponents -- whistle blowers among them -- kill people.